One‐year usage patterns of <scp>SGLT</scp> ‐2 inhibitors and <scp>GLP</scp> ‐1 receptor agonists in individuals with type 2 diabetes in a real‐world population
Distinct clinical and biochemical characteristics are associated with poor adherence versus discontinuation. Understanding these patterns is crucial for developing targeted strategies to improve sustained use, ultimately enhancing treatment outcomes for people with type 2 diabetes.
Authors
- Rory J. McCrimmon (ORCID: https://orcid.org/0000-0002-3957-1981)
- Louise A. Donnelly (ORCID: https://orcid.org/0000-0003-4902-1040)
- Ewan R. Pearson (ORCID: https://orcid.org/0000-0001-9237-8585)
- K P Singh (ORCID: https://orcid.org/0000-0002-2702-3611)
Institutions
- University of Dundee (GB)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1111/dom.70269
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- University of Dundee
- European Federation of Pharmaceutical Industries and Associations
- European Commission